0001209191-19-053698.txt : 20191021
0001209191-19-053698.hdr.sgml : 20191021
20191021162909
ACCESSION NUMBER: 0001209191-19-053698
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191017
FILED AS OF DATE: 20191021
DATE AS OF CHANGE: 20191021
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Parini Michael
CENTRAL INDEX KEY: 0001661567
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 191159817
MAIL ADDRESS:
STREET 1: C/O VERTEX PHARMACEUTICALS, INC.
STREET 2: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-10-17
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001661567
Parini Michael
50 NORTHERN AVENUE
BOSTON
MA
02210
0
1
0
0
EVP, CL&AO
Common Stock
2019-10-17
4
M
0
4250
122.45
A
39253
D
Common Stock
2019-10-17
4
S
0
4250
177.80
D
35003
D
Stock Option (Right to Buy)
122.45
2019-10-17
4
M
0
4250
0.00
D
2026-01-03
Common Stock
4250
4250
D
Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1.
The option vests in 16 quarterly installments from 01/04/2016.
/s/ Omar White, Attorney-in-Fact
2019-10-21